Cellectar
is a New Jersey-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read moreCellectar
is a New Jersey-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
News
Partnership
Dec 16, 2025
GlobeNewswire
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
Conference Presentation
Sep 05, 2025
GlobeNewswire
Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September
Funding
Jul 03, 2025
GlobeNewswire
Cellectar received $6.9M in Post-IPO Equity Funding
Cellectar Competitors
1
2
3
4
5
6